Editas Medicine (EDIT) Reports Q2 Loss of $0.69

August 6, 2019 5:08 PM

Editas Medicine (NASDAQ: EDIT) reported Q2 EPS of ($0.69), versus ($0.82) reported last year. Revenue for the quarter came in ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found